ELFABRIO 5 mg/2.5mL

Elfabrio 5 mg/2.5mL is an intravenous solution containing pegunigalsidase alfa, used for enzyme replacement therapy. This single-dose injection is manufactured by Chiesi USA, Inc. and is designed for specific medical conditions.

Elfabrio is primarily used for enzyme replacement therapy. It is administered intravenously to address certain medical conditions that require enzyme supplementation. The active ingredient, pegunigalsidase alfa, helps in managing these conditions by providing the necessary enzymes that the body may lack.

Common effects of Elfabrio may include reactions at the injection site, such as redness or swelling. Some individuals might experience general discomfort or mild allergic reactions. It is important to monitor for any adverse effects and consult a healthcare provider if concerns arise.

Elfabrio should be handled with care, ensuring proper storage and administration procedures. It is crucial to follow the guidelines provided by healthcare professionals to minimize risks. Always check the packaging for any specific instructions and ensure the solution is clear before use.

Elfabrio may interact with other medications or substances, including certain enzymes or proteins. It is advisable to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and other substances that affect the immune system should be used with caution.